<DOC>
	<DOCNO>NCT02442219</DOCNO>
	<brief_summary>Persons coeliac disease treat gluten free diet ask give blood new diagnostic blood test . In test investigator use multimerized HLA bound different gliadin-peptides ( tetramer ) help flow-cytometer identify ( along relevant T-cell-markers ) gluten specific T-cells . Investigators believe cell present person coeliac disease regardless gluten-intake . Investigators compare finding two control group ; Persons gluten free diet celiac disease exclude ( gluten sensitive group ) person gluten contain diet ( healthy control group ) . In initial main study investigator look HLA DQ2.5 individual , comprise &gt; 90 % person coeliac disease .</brief_summary>
	<brief_title>A Blood Based Diagnostic Test Coeliac Disease</brief_title>
	<detailed_description />
	<mesh_term>Celiac Disease</mesh_term>
	<criteria>HLA DQ2.5 positives primary blind study ( HLAtypes ie DQ8 DQ2.2 later unblinded study ) In gluten free group : Diagnosis must confirm duodenal biopsy do sufficient time gluten contain diet participant must follow glutenfree diet since . Drugs influence immune system use last three month Infected Hepatitis B , C HIV Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>gluten</keyword>
	<keyword>Tetramer</keyword>
</DOC>